Profiles

Keywords
Last Name
Institution

Meenakshi Jolly

Concepts (286)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lupus Erythematosus, Systemic
71
2020
177
23.550
Why?
Quality of Life
36
2020
604
8.100
Why?
Health Status
11
2018
250
3.010
Why?
Severity of Illness Index
28
2020
1220
2.840
Why?
Psychometrics
15
2020
284
2.790
Why?
Rheumatology
6
2019
80
2.420
Why?
Body Image
6
2017
38
2.390
Why?
Adult
53
2020
9591
2.090
Why?
Self Report
7
2017
217
1.980
Why?
Female
63
2020
17657
1.800
Why?
Patient Outcome Assessment
3
2015
48
1.740
Why?
Reproducibility of Results
19
2020
857
1.740
Why?
Middle Aged
46
2020
11053
1.730
Why?
Humans
80
2020
29841
1.670
Why?
Cross-Cultural Comparison
8
2020
40
1.580
Why?
Male
47
2020
17153
1.410
Why?
Pain
7
2020
315
1.320
Why?
Fatigue
4
2020
66
1.180
Why?
Lupus Erythematosus, Cutaneous
2
2014
5
1.140
Why?
Health Status Indicators
3
2014
82
1.100
Why?
Cross-Sectional Studies
13
2020
915
1.090
Why?
Interferon-alpha
7
2014
82
0.980
Why?
Sickness Impact Profile
4
2014
21
0.920
Why?
Antibodies, Antinuclear
5
2018
21
0.920
Why?
Depression
4
2020
490
0.920
Why?
Pain Measurement
5
2019
470
0.890
Why?
Lupus Nephritis
2
2017
31
0.800
Why?
Outpatient Clinics, Hospital
1
2018
14
0.800
Why?
Delivery of Health Care, Integrated
1
2018
30
0.780
Why?
Quality Indicators, Health Care
1
2018
44
0.770
Why?
Academic Medical Centers
1
2019
156
0.740
Why?
Hydroxychloroquine
2
2016
7
0.740
Why?
Cost of Illness
2
2015
61
0.730
Why?
Factor Analysis, Statistical
7
2020
75
0.730
Why?
Ethnic Groups
2
2018
176
0.730
Why?
Unnecessary Procedures
1
2017
30
0.700
Why?
Physicians
3
2015
112
0.690
Why?
Young Adult
12
2020
2198
0.690
Why?
Tattooing
2
2007
2
0.680
Why?
Culture
2
2013
30
0.680
Why?
Antirheumatic Agents
2
2016
94
0.660
Why?
Canada
4
2018
55
0.660
Why?
Biological Products
1
2016
31
0.660
Why?
Adolescent
11
2020
2591
0.630
Why?
Lupus Erythematosus, Discoid
2
2005
7
0.610
Why?
Linear Models
6
2018
277
0.610
Why?
Immunoglobulin lambda-Chains
1
2014
4
0.590
Why?
Immunoglobulin kappa-Chains
1
2014
5
0.590
Why?
Interleukin-10
1
2014
42
0.580
Why?
Language
5
2020
76
0.570
Why?
Autoantibodies
8
2013
114
0.560
Why?
Interleukin-6
1
2014
116
0.560
Why?
Arthritis, Rheumatoid
4
2019
374
0.560
Why?
Posterior Leukoencephalopathy Syndrome
1
2013
14
0.560
Why?
United States
7
2018
2402
0.540
Why?
Teaching
2
2019
62
0.540
Why?
Caregivers
1
2015
140
0.540
Why?
Cultural Characteristics
1
2013
25
0.530
Why?
Dermatology
1
2012
8
0.530
Why?
Patient Education as Topic
1
2014
191
0.530
Why?
Diagnostic Self Evaluation
1
2012
14
0.530
Why?
Hospitals, County
1
2012
4
0.530
Why?
Treatment Outcome
10
2018
3788
0.520
Why?
Hospitals, University
1
2012
45
0.510
Why?
Adaptation, Psychological
5
2016
170
0.500
Why?
Body Dysmorphic Disorders
1
2011
4
0.500
Why?
Longitudinal Studies
6
2020
1388
0.490
Why?
Immunoglobulin Light Chains
1
2011
9
0.480
Why?
Emotions
3
2017
95
0.480
Why?
Polymorphism, Single Nucleotide
8
2017
327
0.480
Why?
Quality of Health Care
1
2012
134
0.460
Why?
Benchmarking
1
2010
28
0.450
Why?
Demography
1
2010
80
0.430
Why?
Income
1
2010
71
0.420
Why?
Genetic Predisposition to Disease
6
2018
469
0.420
Why?
Activities of Daily Living
2
2012
470
0.410
Why?
Clinical Trials as Topic
4
2016
382
0.390
Why?
Case-Control Studies
6
2014
684
0.380
Why?
Predictive Value of Tests
4
2017
617
0.380
Why?
Randomized Controlled Trials as Topic
3
2016
357
0.370
Why?
Stress, Psychological
3
2020
272
0.370
Why?
Paracentesis
1
2007
4
0.360
Why?
Vasculitis, Leukocytoclastic, Cutaneous
1
2007
2
0.360
Why?
Suction
1
2007
45
0.360
Why?
Genital Diseases, Female
1
2006
11
0.350
Why?
Reference Values
3
2014
255
0.340
Why?
Hyperuricemia
1
2006
5
0.340
Why?
Aged
9
2020
9833
0.330
Why?
Chronic Disease
2
2005
530
0.330
Why?
Takayasu Arteritis
1
2005
1
0.320
Why?
Uveitis
1
2005
7
0.320
Why?
Vasculitis
1
2005
35
0.310
Why?
Chicago
2
2018
916
0.310
Why?
Pre-Eclampsia
1
2004
8
0.310
Why?
Leukoencephalopathy, Progressive Multifocal
1
2007
117
0.310
Why?
Chlamydia trachomatis
1
2004
16
0.300
Why?
Chlamydia Infections
1
2004
8
0.300
Why?
Tumor Necrosis Factor-alpha
1
2005
227
0.290
Why?
African Americans
6
2015
739
0.290
Why?
Pregnancy Complications
1
2004
56
0.290
Why?
Heart Diseases
1
2005
97
0.280
Why?
Prognosis
3
2014
1025
0.280
Why?
Translations
2
2013
14
0.280
Why?
Antibodies, Monoclonal
1
2005
309
0.280
Why?
Depressive Disorder
2
2018
213
0.280
Why?
Diagnosis, Differential
3
2013
466
0.260
Why?
Comorbidity
3
2013
555
0.250
Why?
Cardiovascular Diseases
1
2006
370
0.250
Why?
Sex Factors
2
2018
524
0.240
Why?
Prospective Studies
3
2020
1809
0.230
Why?
Hispanic Americans
5
2015
218
0.230
Why?
Regression Analysis
3
2020
318
0.220
Why?
Autoimmunity
2
2010
23
0.220
Why?
Health Surveys
2
2017
100
0.220
Why?
Azacitidine
1
2019
12
0.210
Why?
Cohort Studies
6
2017
1911
0.210
Why?
Multivariate Analysis
2
2018
390
0.210
Why?
Asia
1
2018
10
0.200
Why?
Appointments and Schedules
1
2018
15
0.200
Why?
Europe
1
2018
83
0.200
Why?
Morbidity
1
2018
71
0.200
Why?
Faculty, Medical
1
2019
30
0.200
Why?
Patient Acuity
1
2018
10
0.200
Why?
Sex Distribution
1
2018
90
0.200
Why?
Mentors
1
2019
38
0.200
Why?
Age Factors
3
2016
912
0.200
Why?
Enzyme Inhibitors
1
2019
160
0.200
Why?
Workload
1
2018
39
0.200
Why?
Phenotype
4
2012
360
0.190
Why?
European Continental Ancestry Group
7
2018
593
0.190
Why?
Biomedical Research
1
2019
85
0.190
Why?
Arthritis, Experimental
1
2019
139
0.190
Why?
Interferon Type I
2
2017
20
0.190
Why?
Pilot Projects
2
2020
425
0.180
Why?
DNA Methylation
1
2019
154
0.180
Why?
Genome-Wide Association Study
4
2012
304
0.180
Why?
Philippines
2
2017
3
0.180
Why?
Blood Sedimentation
1
2017
65
0.180
Why?
Psychiatric Status Rating Scales
1
2018
386
0.180
Why?
Health Care Surveys
1
2017
76
0.180
Why?
Toll-Like Receptors
1
2017
29
0.180
Why?
Risk Assessment
2
2014
794
0.180
Why?
Retrospective Studies
2
2018
3303
0.180
Why?
Mental Health
1
2017
103
0.170
Why?
Illinois
1
2017
265
0.170
Why?
Health Status Disparities
1
2017
63
0.170
Why?
Macrophages
1
2017
110
0.170
Why?
France
1
2016
38
0.170
Why?
Socioeconomic Factors
3
2016
351
0.160
Why?
Arthralgia
2
2008
115
0.160
Why?
Sleep Initiation and Maintenance Disorders
1
2017
115
0.160
Why?
Hong Kong
1
2015
3
0.160
Why?
Interferon Regulatory Factor-7
2
2017
4
0.160
Why?
Software
1
2015
73
0.160
Why?
Self Concept
2
2012
52
0.150
Why?
Cosmetic Techniques
1
2014
4
0.150
Why?
Critical Pathways
1
2014
23
0.150
Why?
Professional-Patient Relations
1
2015
32
0.150
Why?
Asian Continental Ancestry Group
1
2015
51
0.150
Why?
Focus Groups
1
2014
90
0.150
Why?
Magnetic Resonance Imaging
2
2013
1220
0.150
Why?
Double-Blind Method
1
2016
541
0.150
Why?
Time Factors
2
2017
1894
0.150
Why?
Chi-Square Distribution
1
2014
181
0.150
Why?
Goals
1
2014
49
0.140
Why?
Dose-Response Relationship, Drug
1
2015
524
0.140
Why?
Interferon Regulatory Factors
1
2013
2
0.140
Why?
Turkey
1
2013
5
0.140
Why?
Sleep
1
2017
326
0.140
Why?
Genetic Variation
2
2011
117
0.140
Why?
Promoter Regions, Genetic
2
2011
103
0.140
Why?
Latin America
1
2013
7
0.140
Why?
Combined Modality Therapy
1
2014
467
0.140
Why?
Matched-Pair Analysis
1
2012
24
0.130
Why?
Multiple Sclerosis
1
2013
87
0.130
Why?
Self-Assessment
1
2012
28
0.130
Why?
Feedback
1
2012
26
0.130
Why?
Osteopontin
1
2011
4
0.120
Why?
Ubiquitin-Conjugating Enzymes
1
2011
6
0.120
Why?
Disease Management
1
2013
149
0.120
Why?
DEAD-box RNA Helicases
1
2011
5
0.120
Why?
Quality Improvement
1
2013
169
0.120
Why?
Complementary Therapies
1
2011
15
0.120
Why?
Gene Expression Profiling
1
2012
180
0.120
Why?
DNA
4
2013
140
0.120
Why?
Sensitivity and Specificity
1
2013
592
0.120
Why?
Genetic Association Studies
1
2011
87
0.120
Why?
Alleles
4
2011
219
0.110
Why?
Class III Phosphatidylinositol 3-Kinases
1
2010
1
0.110
Why?
Models, Genetic
1
2010
43
0.110
Why?
Aged, 80 and over
2
2019
5016
0.110
Why?
Epitopes
1
2010
91
0.110
Why?
Phosphatidylinositol 3-Kinases
1
2010
48
0.110
Why?
Intracellular Signaling Peptides and Proteins
1
2010
55
0.110
Why?
African Continental Ancestry Group
2
2018
172
0.110
Why?
Self-Examination
1
2009
3
0.100
Why?
Nuclear Proteins
1
2010
96
0.100
Why?
California
3
2017
33
0.100
Why?
Social Environment
1
2010
93
0.100
Why?
Disease Models, Animal
2
2019
813
0.100
Why?
Follow-Up Studies
1
2014
2017
0.100
Why?
Educational Status
1
2010
271
0.100
Why?
Analgesics, Non-Narcotic
1
2008
18
0.100
Why?
Cytokines
1
2010
344
0.100
Why?
Prevalence
2
2011
533
0.090
Why?
Therapeutic Irrigation
1
2007
63
0.090
Why?
Fatal Outcome
1
2007
76
0.090
Why?
Patient Satisfaction
1
2010
298
0.090
Why?
Animals
3
2019
5125
0.090
Why?
Education, Medical, Undergraduate
1
2007
35
0.090
Why?
Vulva
1
2006
3
0.090
Why?
Injections, Intra-Articular
1
2007
77
0.090
Why?
Data Collection
1
2007
118
0.090
Why?
Joints
1
2007
101
0.080
Why?
Skin Diseases
1
2006
37
0.080
Why?
Cognition
1
2014
1067
0.080
Why?
Hepatitis B
1
2005
20
0.080
Why?
Probability
1
2005
107
0.080
Why?
Disability Evaluation
2
2020
327
0.080
Why?
Autoimmune Diseases
2
2019
63
0.080
Why?
Genotype
3
2011
435
0.080
Why?
Pregnancy Outcome
1
2004
20
0.080
Why?
Sulfasalazine
1
2004
4
0.080
Why?
Lactones
1
2004
14
0.070
Why?
Sulfones
1
2004
27
0.070
Why?
Doxycycline
1
2004
23
0.070
Why?
Internship and Residency
1
2007
182
0.070
Why?
Methotrexate
1
2004
47
0.070
Why?
Myocardial Infarction
1
2005
188
0.070
Why?
Drug Therapy, Combination
1
2004
264
0.070
Why?
Synovial Fluid
1
2004
137
0.070
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2004
106
0.070
Why?
Osteoarthritis, Knee
1
2008
355
0.070
Why?
Pregnancy
1
2004
443
0.070
Why?
Mice
2
2019
1805
0.070
Why?
Hypertension
1
2004
266
0.060
Why?
Ribonucleoproteins
2
2011
3
0.060
Why?
Cell Line
2
2012
351
0.060
Why?
Egypt
1
2020
3
0.060
Why?
Anti-Bacterial Agents
1
2004
401
0.060
Why?
Polymorphism, Genetic
2
2011
95
0.060
Why?
Chromatin Immunoprecipitation
1
2019
28
0.050
Why?
Gene Silencing
1
2019
26
0.050
Why?
Anxiety
1
2020
149
0.050
Why?
B-Lymphocytes
1
2019
94
0.050
Why?
Flow Cytometry
1
2019
224
0.050
Why?
Complement C1q
1
2018
3
0.050
Why?
Malaria
1
2018
5
0.050
Why?
Immunoglobulin M
1
2018
22
0.050
Why?
Glucocorticoids
1
2018
75
0.050
Why?
Immunoglobulin G
1
2018
136
0.050
Why?
Georgia
1
2017
16
0.050
Why?
Southeastern United States
1
2017
15
0.050
Why?
Mice, Inbred MRL lpr
1
2017
3
0.050
Why?
Interferon Regulatory Factor-3
1
2017
3
0.050
Why?
Japan
1
2016
14
0.040
Why?
Australia
1
2016
43
0.040
Why?
Social Class
1
2017
72
0.040
Why?
Proto-Oncogene Proteins c-akt
1
2017
67
0.040
Why?
Registries
1
2017
195
0.040
Why?
Child
1
2020
1505
0.040
Why?
Disabled Persons
1
2016
108
0.040
Why?
Risk Factors
2
2011
2549
0.030
Why?
3' Untranslated Regions
1
2011
4
0.030
Why?
Anemia, Hemolytic
1
2011
3
0.030
Why?
Autoantigens
1
2011
36
0.030
Why?
Thrombocytopenia
1
2011
31
0.030
Why?
Mexican Americans
1
2011
28
0.030
Why?
Receptors, Lysophosphatidic Acid
1
2010
1
0.030
Why?
Databases, Genetic
1
2010
12
0.030
Why?
Principal Component Analysis
1
2010
27
0.030
Why?
Aminopeptidases
1
2010
7
0.030
Why?
Protein Structure, Quaternary
1
2010
8
0.030
Why?
Antibody Specificity
1
2010
58
0.030
Why?
Immunoprecipitation
1
2010
27
0.030
Why?
Immunoblotting
1
2010
64
0.030
Why?
Transfection
1
2010
150
0.030
Why?
Gene Frequency
1
2010
85
0.030
Why?
Interferon-gamma
1
2010
117
0.030
Why?
Genetic Loci
1
2010
68
0.030
Why?
Polymerase Chain Reaction
1
2010
208
0.030
Why?
DNA-Binding Proteins
1
2010
245
0.020
Why?
Gene Expression Regulation
1
2010
345
0.020
Why?
Signal Transduction
1
2011
563
0.020
Why?
Algorithms
1
2010
414
0.020
Why?
Knee Joint
1
2008
721
0.010
Why?
Jolly's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description